CV Sciences’ Pharmaceutical Division is developing synthetically-formulated cannabidiol for use in drug development activities, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions.
CV Sciences’ Consumer Products Division delivers botanical-based cannabidiol products that enhance quality of life. Currently distributed nationally in health food stores, health care provider’s offices and online, each consumer products brand is backed by a formal safety review, growing body of case reports, and physician’s recommendations.
2688 South Rainbow Blvd, Suite B
Las Vegas, NV 89146
United States of America